Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

February 10, 2004; 62 (3) Brief Communications

The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994

D. S. Knopman, R. C. Petersen, S. D. Edland, R. H. Cha, W. A. Rocca
First published February 9, 2004, DOI: https://doi.org/10.1212/01.WNL.0000106827.39764.7E
D. S. Knopman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. C. Petersen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. D. Edland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. H. Cha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. A. Rocca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994
D. S. Knopman, R. C. Petersen, S. D. Edland, R. H. Cha, W. A. Rocca
Neurology Feb 2004, 62 (3) 506-508; DOI: 10.1212/01.WNL.0000106827.39764.7E

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
402

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

The records-linkage system of the Rochester Epidemiology Project was used to ascertain incident cases of frontotemporal lobar degeneration (FTLD) in Rochester, MN, from 1990 through 1994. Four cases of FTLD were identified (all women); two were confirmed neuropathologically. All were of the behavioral-dysexecutive type and had onset before age 70. The incidence rates (new cases per 100,000 person-years) were 2.2 for ages 40 to 49, 3.3 for ages 50 to 59, and 8.9 for ages 60 to 69. For comparison, the corresponding rates for Alzheimer disease were 0.0, 3.3, and 88.9.

Frontotemporal lobar degeneration (FTLD) is believed to be much less common than Alzheimer disease (AD). Based on autopsy series, FTLD appears to be approximately 10 times less common than AD.1–3⇓⇓ Two recent epidemiologic studies from Europe yielded prevalence estimates that were disparate.4,5⇓ We investigated the incidence of FTLD in the town of Rochester, MN, from 1990 through 1994.

Methods.

We ascertained new cases of dementia from 1990 through 1994 using the records-linkage system of the Rochester Epidemiology Project, as described previously.6 We searched computerized patient indexes for 132 specific diagnostic codes that might indicate dementia. Any subject who received at least one of the study codes during the 5 years of the study (or during the subsequent 6 years) was considered as a potential case. All medical records of each potential case were screened by a specifically trained nurse abstracter, and a diagnosis was obtained, as previously described.6 The study neurologists confirmed the presence of dementia, classified the dementia by type, and determined the year of onset.

The principal sources of diagnostic information were the medical history, neurologic examinations, and neuroimaging studies as recorded historically in the patient dossier of the records-linkage system. Diagnostic criteria for dementia and for AD were those of the Diagnostic and Statistical Manual for Mental Disorders (4th ed.).7 We considered a historical diagnosis of FTLD (diagnosis of an FTLD syndrome made by the treating physician or specialist at the time of evaluation) and a study diagnosis of FTLD (retrospective application of the study criteria to the clinical information in the medical record). The study diagnosis was established by the first author using the recent consensus criteria.8,9⇓ The consensus criteria were not available to the treating physicians or specialists who made the historical diagnosis between 1990 and 1994 (or shortly after). We recognized three syndromes of FTLD8,9⇓: the behavioral-dysexecutive syndrome of frontotemporal dementia, the primary progressive aphasia syndrome, and the semantic dementia syndrome. We also used available neuroimaging data to support the diagnosis of FTLD. Finally, we identified all cases from the cohort who had died and had neuropathologic examinations.

We calculated age-specific incidence rates. The number of person-years at risk was estimated from census data with adjustment for prevalent cases of dementia, as described elsewhere.6 Average annual incidence rates are reported by 10-year age classes.

Results.

There were 60 patients who had onset of dementia under age 70 from 1990 through 1994. AD was diagnosed in 21 patients (35%). There were four cases of FTLD, all women, all of the behavioral-dysexecutive type (table). FTLD represented 7% of all the cases of dementia with onset under age 70. The four cases had been recognized and correctly diagnosed historically by their treating physicians. All four had been seen by a Mayo Clinic behavioral neurologist. Three of the four patients had MR scans that demonstrated volume loss in the temporal or frontal lobes or in both. The fourth patient had a structural imaging study that was nondiagnostic; however, she also had an SPECT study that showed reduced perfusion in frontal regions. Two of the four patients had died, and the diagnosis of FTLD was confirmed neuropathologically.

View this table:
  • View inline
  • View popup

Table. Clinical features of the four incident cases of FTLD, Rochester, MN, 1990 through 1994

One additional man had a clinical syndrome of frontotemporal dementia with onset at age 43; however, the imaging finding of bilateral putaminal encephalomalacia was inconsistent with our definition of FTLD. No other cases with FTLD were identified historically or on medical record review among the 504 cases who were age 70 or older at onset of dementia from 1990 through 1994. Finally, among the 114 autopsied cases from the entire incidence series (13 with onset below age 70 and 101 who were age 70 or older), we found only the 2 cases of FTLD described above.

The ratio of FTLD relative to AD was approximately 1:5.25 under age 70. The incidence rate of FTLD (new cases per 100,000 person-years) was 2.2 in the 40- to 49-year age class (one case over 45,351 person-years), 3.3 in the 50- to 59-year age class (one case over 30,589 person-years), and 8.9 in the 60- to 69-year age class (two cases over 22,503 person-years) (figure). For comparison, the corresponding figures for AD were 0.0, 3.3, and 88.9 (see the figure).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Age-specific incidence rates of Alzheimer disease (AD) (unpublished findings) and frontotemporal lobar degeneration (FTLD) (current study) in Rochester, MN, 1990 through 1994 (new cases per 100,000 person-years).

Discussion.

In our population, FTLD was not as common as in some autopsy studies; however, it was somewhat more common at a younger age than suggested by previous epidemiologic studies.4,5⇓ The fact that all of our cases were women is probably due to chance, given the small number of cases. All cases were of the behavioral-dysexecutive type. There were no cases of primary progressive aphasia or semantic dementia. Although the clinical diagnosis of FTLD can be imperfect, our case definition was conservative and required imaging confirmation.

The prevalence of FTLD from a UK study was 15 per 100,000 in the 45- to 64-year-old population4; the prevalence from a Netherlands study was lower (3.6 per 100,000 among the 50- to 59-year-old and 9.4 per 100,000 among the 60- to 69-year-old population).5 Our incidence rates cannot be directly compared with prevalence figures. However, the duration of survival of our four patients at the time of the study was quite long (two patients died at 5 and 12 years, and two patients were censored alive at 10 and 12 years). If we assume a conservative median survival of 6 years from onset of symptoms,10 our incidence rates would yield a prevalence higher than in both prior studies (incidence × median survival ≈ prevalence; 3.3 × 6 = 19.8 cases per 100,000 for the 50- to 59-year-old and 8.9 × 6 = 53.4 cases per 100,000 for the 60- to 69-year-old population).

Most prior knowledge about the frequency of FTLD came largely from autopsy series. In a dementia brain bank in the Twin Cities, MN,2 FTLD was rare (about 6%); however, it represented 17% of dementia cases that were under age 70 at death. In a neuropathologic review of 382 cases from the State of Florida Brain Bank,3 FTLD constituted 5% of all dementia patients; however, the frequency was 8% for cases below 70 years of age.

The strengths of the current study include the high likelihood that dementia patients under age 70 were detected. Importantly, this includes both FTLD and other types of dementia. Another strength was the availability of autopsy confirmation of diagnoses in half of the cases with FTLD. The weaknesses of this study include the small geographic area examined and the consequent small number of cases of FTLD identified. If we assume that the population of Rochester is a random sample derived from a hypothetical reference population, the CI for the incidence rate of FTLD is quite large (overall incidence rate for the population aged 40 to 69 years = 4.1; 95% CI based on the Poisson distribution = 1.1 to 10.4). Another weakness is our reliance on medical record review to define cases rather than on a prospective assessment. Because the symptoms of FTLD may have been missed or misinterpreted in some cases by the treating physicians, our incidence rates may represent an underestimation of the occurrence of FTLD. On the other hand, of the 60 patients with onset of dementia before age 70, 24 were examined by behavioral neurologists, 12 by other neurologists, and 14 had an unequivocal cause of dementia. Only for 10 cases was the historical diagnosis imperfect, leaving room for incomplete recognition of FTLD symptoms.

Acknowledgments

Supported in part by grants AG 06786 (Mayo Alzheimer’s Disease Patient Registry) and AG 16574 (Mayo Alzheimer’s Disease Research Center) from the National Institute on Aging and made possible by the Rochester Epidemiology Project (grant AR 30582).

  • Received June 8, 2003.
  • Accepted October 14, 2003.

References

  1. ↵
    Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr. 1987; 6: 193–208.
    OpenUrlCrossRefPubMed
  2. ↵
    Knopman DS, Mastri AR, Frey WH II, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology. 1990; 40: 251–256.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002; 16: 203–212.
    OpenUrlCrossRefPubMed
  4. ↵
    Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002; 58: 1615–1621.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003; 126: 2016–2022.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer’s disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002; 59: 1589–1593.
    OpenUrlCrossRefPubMed
  7. ↵
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994.
  8. ↵
    McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001; 58: 1803–1809.
    OpenUrlCrossRefPubMed
  9. ↵
    Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546–1554.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003; 61: 349–354.
    OpenUrlAbstract/FREE Full Text

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All epidemiology
  • Alzheimer's disease
  • Frontotemporal dementia
  • Incidence studies

Alert Me

  • Alert me when eletters are published
Neurology: 98 (24)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise